Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;60(4):e140-e141.
doi: 10.1111/ijd.15286. Epub 2020 Nov 28.

Treatment of hidradenitis suppurativa with certolizumab pegol during pregnancy

Iris Wohlmuth-Wieser  1   2   3 , Raed Alhusayen  1   2
Affiliations

Treatment of hidradenitis suppurativa with certolizumab pegol during pregnancy

Iris Wohlmuth-Wieser et al. Int J Dermatol. 2021 Apr.
No abstract available

PubMed Disclaimer

Comment in

References

    1. Naik HB, Paul M, Cohen SR, et al. Distribution of self-reported hidradenitis suppurativa age at onset. JAMA Dermatol 2019; 155: 971-973.
    1. Perng P, Zampella JG, Okoye GA. Management of hidradenitis suppurativa in pregnancy. J Am Acad Dermatol 2017; 76: 979-989.
    1. Pasut G. Pegylation of biological molecules and potential benefits: pharmacological properties of certolizumab pegol. BioDrugs 2014; 28: S15-S23.
    1. Zouboulis CC, Tzellos T, Kyrgidis A, et al. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol 2017; 177: 1401-1409.
    1. Clowse MEB, Scheuerle AE, Chambers C, et al. Pregnancy outcomes after exposure to certolizumab pegol: updated results from a pharmacovigilance safety database. Arthritis Rheumatol 2018; 70: 1399-1407.

LinkOut - more resources